Meet CDC’s new lead vaccine advisor who thinks shots cause heart disease

In a recent announcement, the Department of Health and Human Services revealed a significant change in leadership at the federal vaccine committee. This committee, known as the Advisory Committee on Immunization Practices (ACIP), has faced scrutiny for its new direction under chairperson Martin Kulldorff, who was appointed after Health Secretary Robert F. Kennedy Jr. dismissed all prior expert advisors in June. Kulldorff, a biostatistician known for his controversial views during the COVID-19 pandemic, is transitioning to a senior position as the chief science officer for the Office of the Assistant Secretary for Planning and Evaluation (ASPE). His departure from ACIP comes amid ongoing debates regarding vaccine safety and efficacy, with critics arguing that his leadership has been more aligned with ideological beliefs than scientific evidence. During his tenure, Kulldorff garnered attention for his role in the Great Barrington Declaration, which controversially suggested allowing the virus to spread unchecked among the population. This stance has drawn considerable backlash from public health experts. While leading ACIP, Kulldorff made several decisions that have been criticized by medical groups, including the removal of thimerosal, a vaccine preservative, from certain flu vaccines, despite research indicating its safety. Additionally, under his leadership, the committee introduced restrictions on the measles, mumps, rubella, and varicella (MMRV) vaccine and attempted to discourage COVID-19 vaccinations, though these efforts largely failed to resonate with the public. As the committee continues to navigate these contentious issues, the implications of Kulldorff's leadership and the recent changes will likely remain a focal point of discussion in the ongoing debate over vaccine policy and public health.